---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-015026"
form_type: "8-K"
ticker: "AUPH"
cik: "0001600620"
company_name: "Aurinia Pharmaceuticals Inc."
filed_at: "2022-05-20T23:59:59+00:00"
generated_at: "2026-06-25T08:42:55.751290+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Aurinia shareholders elect all nine board nominees and approve auditor and say-on-pay at 2022 annual meeting

## Summary
- All nine director nominees elected; for votes ranged from 24.1M (Hagan) to 34.3M (Balakrishnan); broker non-votes 27.9M.
- PricewaterhouseCoopers ratified as independent auditor: 63.3M for, 6.7M against, 2.0M abstain.
- Say-on-pay advisory resolution approved: 33.1M for, 10.5M against, 0.6M abstain; 27.9M broker non-votes.
- Meeting held virtually on May 17, 2022; results reported on May 20, 2022.

## SEC filing metadata
- accession: 0001628280-22-015026
- form_type: 8-K
- ticker: AUPH
- cik: 0001600620
- company_name: Aurinia Pharmaceuticals Inc.
- filed_at: 2022-05-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1600620/000162828022015026/0001628280-22-015026-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1600620/000162828022015026/auph-20220517.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-015026
- JSON: https://secwatch.observer/filing/0001628280-22-015026.json
- Plain text: https://secwatch.observer/filing/0001628280-22-015026.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.